May 12, 2021 / 02:15PM GMT
Juan Esteban Avendano - BofA Securities, Research Division - Associate
I'm Juan Avendano, and I am joined by my colleague, Mike Ryskin. We're part of the life sciences tools equity research team led by Derek De Bruin at Bank of America. I focus on biopharma services, mainly CROs and CDMOs. I want to thank everybody on the webcast for their participation and please feel free to submit your questions through Veracast.
It is my pleasure for me to conduct the following fireside chat with Charles River. We're joined by David Smith, their CFO; and Todd Spencer from Investor Relationships. David and Todd, thank you once again for being here.
David Ross Smith - Charles River Laboratories International, Inc. - Corporate Executive VP & CFO
Thanks for having us.
Questions and Answers:
Juan Esteban Avendano - BofA Securities, Research Division - AssociateSo to set the stage and for those in the audience who might not be familiar with the product portfolio of Charles River, can you provide a quick overview of